Lentivirus purification is the process of isolating and purifying lentivirus. Lentiviral purification process development is crucial to ensure the safety, efficacy, and quality control of gene therapy products. It is the basis for realizing the wide application of gene therapy. CD Formulation can help researchers select the appropriate lentiviral purification solution according to the researcher's project requirements and the experiment's purpose. Over the years of viral vector purification research, we have kept pace with the development of advanced technologies and continuously improved purification and analytical methods to ensure that the fully characterized products are of high purity, efficacy, and safety.
Selection of suitable cell lines for expansion, which can grow in high-density conditions and can be suspension-adapted.
Cells are transfected with lentiviral plasmids to produce lentiviral vectors. We have cationic lipid transfection reagents designed for high-density virus production in cell cultures with high transfection efficiency and low toxicity.
Transfected cells are transferred to different culture systems such as shake flasks, shaker systems, cell factories, or bioreactors for virus production.
After virus production, clarification is required to remove cellular debris and other large particulate matter.
Removes plasmid DNA and host cell nucleic acid impurities.
We use ultrafiltration and dialysis techniques to further purify the virus and improve the recovery and removal of protein and DNA.
Chromatographic purification is performed using a multi-peak chromatography (MMC) step, which combines size exclusion and anion exchange properties in a simple and gentle process.
In the final stage of the purification process, aseptic filtration is achieved by optimizing the filter material, number of layers, etc. to maximize recovery.
We ensure the quality and safety of our products through analytical testing, including sterility, identification, purity and potency testing.
Fig.1 Process of lentivirus vector purification. (CD Formulation)
Polyethylene glycol (PEG) is an uncharged linear molecular structure of polysaccharides, a polymer of ethylene glycol, has a strong dehydrating effect, its ability to destroy the hydration layer on the surface of the protein molecule and precipitation of the protein occurs, PEG alone is used with high non-specific binding, the addition of NaCl helps to precipitate the virus.
Ultracentrifugation is a method of separating, concentrating, and purifying viruses by applying strong centrifugal force with the help of an ultracentrifugal machine according to the different sedimentation coefficients, masses, and densities of substances.
The lentivirus purification column method is to adsorb lentivirus particles through the ionic column, and then use the elution solution to purify the virus, the resulting virus purity is high, but the cost of the experiment is also higher, and the cost-effective for routine experiments is low.
Platforms & Technologies | Content Description |
---|---|
Stable transfection cell production platform | This technology platform provides a plasmid-free approach to lentiviral vector production, saving on plasmid costs and transfection reagent costs, reducing operational complexity and significantly improving process robustness. |
Size exclusion chromatography (SEC) purification process | SEC is a technique used to purify lentiviral vectors by separating viral particles through physical size differences. In one study, SEC was used to purify lentiviral vectors generated from transiently transfected or stably produced cell lines, and protein composition in the purified vectors was analyzed using LC-MS/MS. |
Sterile filtration optimization technology | We maximize the recovery of viral vectors at the end of the purification process by optimizing the filtration material, number of layers and other factors. |
Technology: Lentivirus purification
Journal: Methods Mol Biol
Published: 2016
This study details a simple protocol for the production of lentiviral vectors, describing the triple transfection of lentiviral transfer vectors and lentiviral helper plasmids into HEK-293 cells, followed by the purification of the virosome from the cell culture medium. The current protocol is versatile and can be easily modified to meet the specific needs of researchers to produce relatively high titers of lentiviral vectors that can be used to transduce a variety of cells in vitro and in vivo.
Fig.2 Expression following transduction with lentiviral vector. (Benskey MJ, et al., 2016)
CD Formulation offers a full range of technical services to support researchers in the development of lentiviral vector purification processes. We sincerely hope to cooperate with you and work together to advance the research and development of gene therapy. If you are interested in us, please feel free to contact us.
References